rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Choksi Laboratories Ltd.

526546 CHOKSILA Group (XT)

16 Jul,15:48
55.93
-2.20 (-3.78%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Choksi Laboratories Ltd.

BUYSELL

5,183 58.13 58.60 - 55.40 86.00 - 38.32 39.16

Choksi Laboratories Ltd. is not listed on NSE (View BSE)

News for Choksi Laboratories Ltd.

Podcast...
Podcast Listenership Booming in India: Report
India is the third-largest market for podcast listeners globally, but a recent report reveals that 78% of Indians discovered podcasts less than a year ago. Explore the growth of podcasting in India.
May 03, 2024 14:04
Gitanjali Gems...
Gitanjali Gems Liquidated: NCLT Orders Winding Up
The National Company Law Tribunal (NCLT) has ordered the liquidation of Gitanjali Gems, promoted by Mehul Choksi, due to ongoing investigations and bleak revival prospects. The company was admitted...
Feb 19, 2024 21:00

More News for Choksi Laboratories Ltd. »

(Rs. Crore)

Financial Results of Choksi Laboratories Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales36.7034.4430.0425.6928.16
Operating profit10.2210.248.884.122.84
Interest3.013.493.212.821.89
Gross profit7.386.965.791.791.28
EPS (Rs)1.594.610.30-3.74-5.58

See more in Research Center »

News for Miscellaneous

ADB Retains...
ADB Retains India's FY25 Growth at 7%: Monsoon Boost
The Asian Development Bank (ADB) maintains India's GDP growth forecast at 7% for FY25, citing a rebound in agriculture due to strong monsoon projections. The ADB also predicts a 7.2% growth rate in...
Jul 17, 2024 11:34
Suzuki Tech...
Suzuki Tech Strategy: Light Vehicles, Small Batteries, SDV
Suzuki outlines its technology strategy for the next 10 years, focusing on light vehicles, small batteries for EVs, and software-defined vehicles (SDV).
Jul 17, 2024 10:25
Glenmark Pharma...
Glenmark Pharma Gets USFDA Approval for Seizure Drug
Glenmark Pharmaceuticals has received USFDA approval for its generic Topiramate capsules used to treat seizures. The drug is bioequivalent to Topamax capsules.
Jul 17, 2024 09:47
Ripley & Co to...
Ripley & Co to Modernize Haldia Berth with Rs 600cr Investment
Ripley & Co and Bothra Shipping Services will invest Rs 600 crore to automate and modernize Berth No. 5 at Haldia Dock Complex, boosting cargo handling capacity to 5 million tonnes.
Jul 16, 2024 22:59
India To Set Up...
India To Set Up Centre For Trade Negotiation Skills
India's Commerce Ministry plans to establish a centre for negotiation skills to enhance expertise in FTAs and business deals, aimed at boosting trade and improving IIFT rankings.
Jul 16, 2024 22:07

More News »

Top News

ADB Retains...
ADB Retains India's FY25 Growth at 7%: Monsoon Boost
The Asian Development Bank (ADB) maintains India's GDP growth forecast at 7% for FY25, citing a rebound in agriculture due to strong monsoon projections. The ADB also predicts a 7.2% growth rate in...
Jul 17, 2024 11:34
L'Oreal India...
L'Oreal India Launches Project for Disadvantaged Children
L'Oreal India has launched a CSR initiative in Baddi, Himachal Pradesh to support the education of disadvantaged children from migrant communities. The project, Udaan, aims to help 4,000 children...
Jul 17, 2024 11:00
Suzuki Tech...
Suzuki Tech Strategy: Light Vehicles, Small Batteries, SDV
Suzuki outlines its technology strategy for the next 10 years, focusing on light vehicles, small batteries for EVs, and software-defined vehicles (SDV).
Jul 17, 2024 10:25
Glenmark Pharma...
Glenmark Pharma Gets USFDA Approval for Seizure Drug
Glenmark Pharmaceuticals has received USFDA approval for its generic Topiramate capsules used to treat seizures. The drug is bioequivalent to Topamax capsules.
Jul 17, 2024 09:47
Indian Markets Closed for Muharram: Equity, Currency, Commodities
Indian stock, currency, and commodities markets will be closed on Wednesday, July 17, 2023, in observance of Muharram.
Jul 17, 2024 09:29

More Top News »

Report Card

PE Ratios
35.10
EPS (Rs.)
1.59
Sales (Rs. Cr)
11.12
Face Value (Rs.)
10
Net Profit Margin (%)
9.32
Last Bonus
Last Dividend(%)
Return on Average Equity
15.2

BSE Announcements from Choksi Laboratories Ltd. (See all)

announcement Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - 09 Jul 2024
announcement Closure of Trading Window - 27 Jun 2024

Compare 'Choksi Laboratories Ltd.' with other stocks

  • Syngene International Ltd.
  • 743.75
  • Compare
  • Sun Pharma Advanced Research Company Ltd.
  • 237.20
  • Compare

Most Active

  • Change (Rs.)
  •  

Choksi Laboratories Ltd. performance snapshot

If you had invested Rs.  in Choksi Laboratories Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Choksi Laboratories Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Choksi Laboratories Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close